Financial statements Farmakon
Balance sheet data of FARMAKON
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 868 590,68 | 947 319,01 | 992 692,01 | 1 358 846,74 | 1 873 254,55 | 2 704 825,79 |
| A. Fixed assets | 243 665,77 | 246 600,22 | 226 377,16 | 226 826,13 | 234 931,54 | 250 308,73 |
| B. Current assets | 624 924,91 | 700 718,79 | 766 314,85 | 1 132 020,61 | 1 638 323,01 | 2 454 517,06 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 868 590,68 | 947 319,01 | 992 692,01 | 1 358 846,74 | 1 873 254,55 | 2 704 825,79 |
| A. Equity | -96 020,57 | 5 214,30 | 23 068,13 | 481 753,12 | 949 937,42 | 1 649 285,68 |
| B. Liabilities and provisions for liabilities | 964 611,25 | 942 104,71 | 969 623,88 | 877 093,62 | 923 317,13 | 1 055 540,11 |
| I. Long-term liabilities | 0,00 | - | - | - | 0,00 | 0,00 |
| II. Short-term liabilities | 942 757,06 | - | - | - | 873 118,13 | 1 000 853,31 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.